Short-Term Effect of Zidovudine on Plasma and Genital Human Immunodeficiency Virus Type 1 and Viral Turnover in These Compartments

The effect of zidovudine on plasma and genital human immunodeficiency virus type 1 (HIV-1) was determined in 42 antiretroviral-naive HIV-1-seropositive women in Nairobi. After 7 days of zidovudine treatment, HIV-1 RNA levels decreased by 0.5 to 1.1 log(10) in plasma and genital secretions. HIV-1 RNA...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Virol
Autori principali:	Mbori-Ngacha, Dorothy, Richardson, Barbra A., Overbaugh, Julie, Panteleeff, Dana DeVange, Nduati, Ruth, Steele, Matt, John-Stewart, Grace
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2003
Soggetti:	Vaccines and Antiviral Agents
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164813/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12805473/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.13.7702-7705.2003
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!